Mingshuang Li Selected Research

Mingshuang Li Research Topics

3	Rheumatoid Arthritis 09/2023 - 01/2020
2	Atherosclerosis 10/2022 - 01/2021
2	Infections 04/2022 - 12/2015
2	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2021
1	Tetanus 04/2023
1	Diphtheria 04/2023
1	COVID-19 04/2022
1	Pneumonia (Pneumonitis) 04/2022
1	Ankylosing Spondylitis 01/2022
1	Neoplasms (Cancer) 08/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Disease Progression 01/2020
1	Ear Diseases (Disease, Ear) 09/2018

2	VaccinesIBA 04/2023 - 04/2022
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 08/2021
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2020
1	Therapeutic UsesIBA 09/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2023
1	Pertussis VaccineIBA 04/2023
1	baicalinIBA 10/2022
1	Messenger RNA (mRNA)IBA 04/2022
1	COVID-19 VaccinesIBA 04/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	icotinibIBA 01/2021
1	LipidsIBA 01/2021
1	InterleukinsIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	tanyu tongzhi formulaIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	CollagenIBA 01/2021
1	CholesterolIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	ChemokinesIBA 01/2020
1	Antiparasitic Agents (Antiparasitics)IBA 12/2015

1	Contraindications 04/2022
1	Therapeutics 09/2018